Aceon Related Published Studies
Well-designed clinical trials related to Aceon (Perindopril Erbumine)
Bioequivalence study of two perindopril erbumine tablet formulations in healthy volunteers. [2011]
Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. [2010.12]
Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis. [2010.09.20]
The effect of treatment based on a diuretic (indapamide) +/- ACE inhibitor (perindopril) on fractures in the Hypertension in the Very Elderly Trial (HYVET). [2010.09]
The angiotensin-converting enzyme inhibitor perindopril treatment alters cardiovascular and subjective effects of methamphetamine in humans. [2010.08.30]
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease. [2010.08]
Management of high blood pressure in type 2 diabetes: perindopril/indapamide fixed-dose combination and the ADVANCE trial [corrected]. [2010.07]
Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA study. [2010.05]
Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trial. [2010.05]
Efficacy and safety of diuretics in combination with perindopril in hypertensive stroke patients: Results of the Japan Perindopril and Diuretics on Cerebrovascular Disease Study (J-PADOC). [2010.02]
Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial. [2010.02]
Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial. [2010.02]
Long-term effects of perindopril on left ventricular structure and function in patients with stable coronary artery disease: a conventional and Doppler tissue echocardiographic pilot study. [2009.10]
[Perindopril, amlodipine and telmisartan improve arterial stiffness in patients with hypertension] [2009.10]
Effects of perindopril on cardiac remodelling and prognostic value of pre-discharge quantitative echocardiographic parameters in elderly patients after acute myocardial infarction: the PREAMI echo sub-study. [2009.07]
Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS). [2009.06]
Fixed dose combination of perindopril and indapamide improves peripheral vascular function in essential hypertensive patients. [2009.05]
ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT study. [2009.05]
The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease. [2009.04]
Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: a subgroup analysis of the EUROPA trial. [2009.02]
An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event. [2009.02]
The Rationale and Design of the Perindopril Genetic Association Study (PERGENE): A Pharmacogenetic Analysis of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients with Stable Coronary Artery Disease. [2008.12.10]
Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCE. [2008.06]
Costs and Effects of Secondary Prevention with Perindopril in Stable Coronary Heart Disease in Poland: An Analysis of the EUROPA Study Including 1251 Polish Patients. [2008]
Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial. [2007.10.09]
Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. [2007.10.03]
Effect of perindopril on coronary remodelling: insights from a multicentre, randomized study. [2007.10]
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. [2007.09.08]
Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. [2007.09]
Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study. [2007.09]
Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy. [2007]
The perindopril in elderly people with chronic heart failure (PEP-CHF) study. [2006.10]
Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk. [2006.04]
Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study. [2006.03.27]
Comparative study of taste disturbance by losartan and perindopril in healthy volunteers. [2005.11]
Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack. [2005.10]
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. [2005.09.10]
Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril. [2005.08]
Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension. [2005.07]
The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy. [2005.07]
A comparison of valsartan and perindopril in the treatment of essential hypertension in the malaysian population. [2005.06]
Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. [2005.03.15]
Effect of perindopril on cerebral and renal perfusion on normotensives in mild early ischaemic stroke: a randomized controlled trial. [2005]
The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension. [2004.12]
Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach. [2004.12]
Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria. [2004.11]
Long-term angiotensin-converting enzyme inhibitor perindopril therapy improves cerebral perfusion reserve in patients with previous minor stroke. [2004.09]
Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study. [2004.08]
Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. [2004.08]
Effect of perindopril on cerebral vasomotor reactivity in patients with lacunar infarction. [2004.08]
Effects of the angiotensin-converting enzyme inhibitor perindopril on endothelial injury and hemostasis in rabbit endotoxic shock. [2004.08]
Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry. [2004.05]
Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan. [2004.03]
Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region. [2004.03]
Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study. [2004.03]
Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. [2004.01.07]
Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. [2004.01]
Clinical experience with perindopril in elderly hypertensive patients: a subgroup analysis of a large community trial. [2004]
[Clinical study of the month. The EUROPA study: cardiovascular protection with perindopril in patients with stable coronary heart disease] [2003.11]
Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial. [2003.10]
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). [2003.09.06]
The albuminuric action of atrial natriuretic peptide is not modified by ACE-inhibition with perindopril in Type 2 diabetes. [2003.09]
[Evaluation of different approaches to the treatment of arterial hypertension: combination treatment with low dose perindopril/indapamide versus sequential treatment of stepped-dose treatment] [2003.07]
A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus. [2003.07]
Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation. [2003.06]
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. [2003.05.12]
Influence of perindopril on left ventricular global performance during the early phase of inferior acute myocardial infarction: assessment by Tei index. [2003.05]
Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER. [2003.05]
Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease. [2003.03]
Influence of antihypertensive treatment with perindopril, pindolol or felodipinon plasma leptin concentration in patients with essential hypertension. [2002.11]
Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial. [2002.10]
[Combination of low-dose perindopril/indapamide versus atenolol in the hypertensive patient. Effects on systolic pressure and arterial hemodynamics. REASON Study] [2002.09]
Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design. [2002.09]
Gender influence on the dose-ranging of a low-dose perindopril-indapamide combination in hypertension: effect on systolic and pulse pressure. [2002.08]
[Evaluation of blood pressure self-monitoring of the residual efficacy of telmisartan compared to perindopril. The EVERESTE study] [2002.07]
Effects of perindopril on aldosterone production in the failing human heart. [2002.05.15]
PERindopril-Function of the Endothelium in Coronary Artery Disease Trial: the PERFECT study--sub study of EUROPA: rationale and design. [2002.05]
Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients. [2002.04]
Comparison of perindopril versus captopril for treatment of acute myocardial infarction. [2002.01.15]
Long-term treatment with perindopril ameliorates dobutamine-induced myocardial ischemia in patients with coronary artery disease. [2002.01]
Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension. [2001.11]
Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination. [2001.11]
Impairment of myocardial blood flow reserve in patients with asymptomatic left ventricular dysfunction: effects of ACE-inhibition with perindopril. [2001.10]
A double-blind trial of perindopril and nitrendipine in incipient diabetic nephropathy. [2001.10]
Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. [2001.10]
Pharmacokinetic-pharmacodynamic model for perindoprilat regional haemodynamic effects in healthy volunteers and in congestive heart failure patients. [2001.07]
Antihypertensive efficacy and tolerability of low-dose perindopril/indapamide combination compared with losartan in the treatment of essential hypertension. [2001.05]
Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria. [2001.05]
Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus. [2001.02]
Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease. [2001.02]
Comparison of the effect of perindopril and acebutolol on cerebral hemodynamics in hypertensive patients. [2001.01]
[The comparison of clinical effectiveness of perindopril and acebutolol in the primary hypertension treatment] [2001]
First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group. [2000.09]
Blood pressure reduction and risk of dementia in patients with stroke: rationale of the dementia assessment in PROGRESS (Perindopril Protection Against Recurrent Stroke Study). PROGRESS Management Committee. [2000.05]
PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee. [2000.05]
Antihypertensive efficacy of the ACE-inhibitor perindopril in the elderly. [2000.05]
Fixed low-dose combination therapy in hypertension--a dose response study of perindopril and indapamide. [2000.03]
The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson's disease. [2000.02]
Efficacy and safety of a fixed low-dose perindopril/indapamide combination in essential hypertension. A randomised controlled study. [2000.01]
Long-term renal and cardiovascular effects of antihypertensive treatment regimens based upon isradipine, perindopril and thiazide. [2000]
Effectiveness and metabolic effects of perindopril and diuretics combination in primary hypertension. [1999.11]
|
